SIP 1 / NHERF 2 enhances estrogen receptor alpha transactivation in breast cancer cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  2012cited by this paper
• Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

  2009cited by this paper
• The RNA coregulator SRA, its binding proteins and nuclear receptor signaling activity

  2008cited by this paper
• Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state

  2007cited by this paper
• X chromosomal abnormalities in basal-like human breast cancer.

  2006cited by this paper
• Controlling nuclear receptors: the circular logic of cofactor cycles

  2005cited by this paper
• The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer.

  2005cited by this paper
• CTCF‐dependent enhancer blockers at the upstream region of the chicken α‐globin gene domain

  2004cited by this paper
• “Studies on the estrogen receptor in breast cancer” — 20 years as a target for the treatment and prevention of cancer

  2004cited by this paper
• Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

  2004cited by this paper
• Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas

  2004cited by this paper
• Coregulator function: a key to understanding tissue specificity of selective receptor modulators.

  2004cited by this paper
• The Relative Contribution Exerted by AF-1 and AF-2 Transactivation Functions in Estrogen Receptor α Transcriptional Activity Depends upon the Differentiation Stage of the Cell*

  2004cited by this paper
• Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis

  2003cited by this paper
• DNA binding of nuclear hormone receptors influences their structure and function.

  2003cited by this paper
• Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

  2003cited by this paper
• Signaling Complex Organization by PDZ Domain Proteins

  2002cited by this paper
• Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu.

  2001cited by this paper
• A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.

  2001cited by this paper
• Quantitative real‐time RT‐PCR detection of breast cancer micrometastasis using a multigene marker panel

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Mechanism and role of PDZ domains in signaling complex assembly.

  2001cited by this paper
• Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.

  2001cited by this paper
• Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation

  2001cited by this paper
• p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains*

  2000cited by this paper
• The coregulator exchange in transcriptional functions of nuclear receptors.

  2000cited by this paper
• Evidence for Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) Self-association through PDZ-PDZ Interactions*

  2000cited by this paper
• Expression of the steroid receptor RNA activator in human breast tumors.

  1999cited by this paper
• The Apical Na+/H+ Exchanger Isoform NHE3 Is Regulated by the Actin Cytoskeleton*

  1999cited by this paper
• Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.

  1999cited by this paper
• The nuclear receptor ligand-binding domain: structure and function.

  1998cited by this paper
• Coordination of an Array of Signaling Proteins through Homo- and Heteromeric Interactions Between PDZ Domains and Target Proteins

  1998cited by this paper
• The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

  1998cited by this paper
• A signature motif in transcriptional co-activators mediates binding to nuclear receptors

  1997cited by this paper
• The Human Testis Determining Factor SRY Binds a Nuclear Factor Containing PDZ Protein Interaction Domains*

  1997cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper
• Steroid receptor coactivator-1 is a histone acetyltransferase

  1997cited by this paper
• Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions.

  1994cited by this paper
• Transcription activation by estrogen and progesterone receptors.

  1991cited by this paper
• The human estrogen receptor has two independent nonacidic transcriptional activation functions.

  1989cited by this paper

• Activation of GPER by E2 promotes proliferation, invasion and migration of breast cancer cells by regulating the miR‑124/CD151 pathway

  2021cites this paper
• Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer

  2015cites this paper